Pharmacological treatments for GH-induced insulin resistance

Endocrine Journal

Volumn 46, Issue SUPPL., 1999, Pages

  Sugimoto, Miyuki ^a   Takeda, Noriyuki ^a,b   Hattori, Junko ^a   Yoshino, Kouji ^a   Nakashima, Kazuya ^a   Okumura, Shoji ^a   Ishimori, Masatoshi ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

D chiroinositol; Hyperinsulinemic clamp; Insulin resistance; Recombinant human GH; Troglitazone

Indexed keywords

FATTY ACID; GLUCOSE; GROWTH HORMONE; INOSITOL; INSULIN; TROGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; CALCULATION; CONFERENCE PAPER; CONTROLLED STUDY; DIABETOGENESIS; DRUG POTENCY; FATTY ACID BLOOD LEVEL; GENE TECHNOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; RADIOIMMUNOASSAY; RAT;

EID: 0033017270     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.46.suppl_s51     Document Type: Conference Paper

References (8)

1. Ganda OP, Simonson DC (1993) Growth hormone, acromegaly, and diabetes. Diab Rev 1: 286-300.
2. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669.
3. Ortmeyer HK, Huang LC, Zhang LU, Hansen BC, Larner J (1993) Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, nomal rats given a glucose load, and spontaneously insulin-resistant Rhesus monkeys. Endocrinology 132: 646-651.
4. Souza SC, Frick GP, Wang XZ, Kopchick JJ, Lobo RB, Goodman M (1995) A single arginine residue determines species specificity of the human growth hormone receptor. Proc Natl Acad Sci 92: 959-963.
5. Ng SF, Storlien LH, Kraegen EW, Stuart MC, Chapman GE, Lazarus L (1990) Effect of biosynthetic human growth hormone on insulin action in indivisual tissue of the rat in vivo. Metabolism 39: 264-268.
6. Towns R, Kostyo JL, Colca JR (1994) Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth. Endocrinology 134: 608-613.
7. Møller N, Jørgensen JOL, Abildgard L, Schmitz O (1991) Effects of growth hormone on glucose metabolism. Horm Res 36 (suppl 1): 32-35.
8. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chrisholm DJ, Kraegen EW (1994) A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43: 1203-1210.